Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Klenowski PM. Emerging role for the medial prefrontal cortex in alcohol-seeking behaviors. Addict Behav. 2018;77:102–6.
Noori HR, Cosa Linan A, Spanagel R. Largely overlapping neuronal substrates of reactivity to drug, gambling, food and sexual cues: a comprehensive meta-analysis. Eur Neuropsychopharmacol. 2016;26:1419–30.
van der Vaart A, Meng X, Bowers MS, Batman AM, Aliev F, Farris SP, et al. Glycogen synthase kinase 3 beta regulates ethanol consumption and is a risk factor for alcohol dependence. Neuropsychopharmacology 2018. [Epub ahead of print].
Luo J. GSK3beta in ethanol neurotoxicity. Mol Neurobiol. 2009;40:108–21.
Crofton EJ, Nenov MN, Zhang Y, Scala F, Page SA, McCue DL, et al. Glycogen synthase kinase 3 beta alters anxiety-, depression-, and addiction-related behaviors and neuronal activity in the nucleus accumbens shell. Neuropharmacology. 2017;117:49–60.
Shi X, Miller JS, Harper LJ, Poole RL, Gould TJ, Unterwald EM. Reactivation of cocaine reward memory engages the Akt/GSK3/mTOR signaling pathway and can be disrupted by GSK3 inhibition. Psychopharmacology. 2014;231:3109–18.
Connor JP, Gullo MJ, White A, Kelly AB. Polysubstance use: diagnostic challenges, patterns of use and health. Curr Opin Psychiatry. 2014;27:269–75.
Logrip ML, Barak S, Warnault V, Ron D. Corticostriatal BDNF and alcohol addiction. Brain Res. 2015;1628(Pt A):60–7.
Funding and Disclosure
This work was funded by NIMH R01 MH111604 and NIDA R01 DA040621. The authors have no conflicts to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Eagle, A.L., Robison, A.J. GSK3β in the prefrontal cortex: a molecular handle specific to addiction pathology?. Neuropsychopharmacol 43, 2497–2498 (2018). https://doi.org/10.1038/s41386-018-0224-4
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41386-018-0224-4